Oral Arsenic Trioxide (Rasayani Biologics)

三氧化二砷口服制剂 (Rasayani Biologics)

Report date: 2025/07/07 20:00:09

Base Information

Drug NameOral Arsenic Trioxide (Rasayani Biologics)
Drug Alias NameNTAX-44
ClassificationSmall molecules
Mechanisms of ActionThioredoxin reductase inhibitorsImmunostimulantsDNA synthesis inhibitors +[4] 
TargetsThioredoxin reductase
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLeukemia, Promyelocytic, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRasayani Biologics Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRasayani Biologics Pvt LtdInstituto Do Cancer Do Estado De São Paulo
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsLeukemia, Promyelocytic, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A